Why Newfield Exploration (NFX) Is Up on Wednesday

NEW YORK (TheStreet) -- Newfield Exploration (NFX) is higher on Wednesday after fourth-quarter earnings came in better than expected.

By noon, shares had added 6.4% to $27.30.

In the three months to December, the oil and gas producer recorded adjusted net income of $66 million, or 48 cents a share. Analysts surveyed by Thomson Reuters had anticipated earnings of 47 cents a share.

Revenue of $498 million was 23% lower than a year earlier and missed expectations by $86.4 million. Total sales excluded income of $232 million from discontinued operations including the sale of Newfield's Malaysian business and the ongoing divestment of its China business.

Also See: QEP Resources Plummets After Earnings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings team rates NEWFIELD EXPLORATION CO as a Sell with a ratings score of D+. The team has this to say about their recommendation:

"We rate NEWFIELD EXPLORATION CO (NFX) a SELL. This is driven by a few notable weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk and disappointing return on equity."

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Dow Skids and Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Dow Skids and Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar